Skip to main content

Hypertrophic Cardiomyopathy

Inderjit Singh, MD and Navpreet K. Singh, MD Reviewed 04/2024
 


BASICS

DESCRIPTION

  • Hypertrophic cardiomyopathy (HCM) is a form of primary myocardial hypertrophy, with or without presence of left ventricular outflow tract (LVOT) obstruction; it is characterized by f...

DIAGNOSIS

HISTORY

  • Symptoms of heart failure: dyspnea, paroxysmal nocturnal dyspnea, fatigue

  • Anginal chest pain

  • Palpitations

  • Exertional syncope or presyncope

  • Symptoms may be worsened by anemia, hot and humi...

TREATMENT

  • For patients who are genotype-positive but are phenotype-negative, continued follow-up with no treatment may suffice.

  • Treatment is indicated for symptomatic patients.

  • Patients at high risk for...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

  • Follow-up every 1-2 years is recommended for phenotype-positive stable patients, with clinical re-evaluation, Holter, and echocardiogram (1)[C]. Re-evaluation is...

REFERENCES

1
Writing Committee Members; SR Ommen, Mital S, Burke MA, et al.2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the America...

ADDITIONAL READING

Ommen SR, Semsarian C. Hypertrophic cardiomyopathy: a practical approach to guideline directed management. Lancet. 2021;398(10316):2102-2108. PMID: 34600606. ...

CODES

ICD10

  • I42.1 Obstructive hypertrophic cardiomyopathy

  • I42.2 Other hypertrophic cardiomyopathy

SNOMED

  • 233873004 Hypertrophic cardiomyopathy

  • 45227007 Hypertrophic obstructive cardiomyopathy

  • 472324001 Feta...

CLINICAL PEARLS

  • HCM should be considered in all patients with a history of exercise syncope or unexplained SCD. It is the most common cause of SCD in young athletes in the United States. Family histor...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×